WHA25.61  Quality,  safety  and  efficacy  of drugs 
The Twenty-fifth  World  Health  Assembly, 
Having  examined  the  report  of the  Director-General  on  the  quality,  safety  and  efficacy  of drugs  ； 
Mindful  of the  importance  of developing  a comprehensive  approach  to ensuring  drug  quality,  safety 
and efficacy,  monitoring  adverse  reactions,  and  developing  and  disseminating  accurate  information  about 
drugs  ； 
Convinced  of the  need  to assist  national  health  authorities  to meet  their  responsibilities  in relation  to 
drug  quality,  safety  and  efficacy, 
1. NOTES  with  appreciation  the  activities  that  have  been  undertaken  in accordance  with  resolution 
WHA24.56; 
2. RECOMMENDS  that  governments,  if they  deem  it necessary,  take  suitable  measures  for  giving  the  public 
appropriate  information  about  the  use,  hazards  and  limitations  of drugs  ； 
3. REQUESTS  the Director-General  to report  to the fifty-first  session  of the Executive  Board  and  the Twentysixth  World  Health  Assembly  : 
(a) on  the  feasibility  of an international  information  system  providing  data  on the  scientific  basis 
and the  conditions  of registration  of individual  drugs; 
(b) on  practicable  minimum  requirements  and  on other  efforts  to develop  a comprehensive  approach 
to ensuring  the  quality,  safety  and  efficacy  of drugs,  including  the  feasibility  of implementing 
Article  21 (d) and  (e) of the  WHO  Constitution;  and 
(c) on  the  cost  of any  action  foreseen; 
4. URGES  all countries  participating  in the  monitoring  scheme  to ensure  that  reports  of adverse  reactions 
after  validation  are  forwarded  regularly  and  with  the minimum  delay  to the Organization;  and 
5. REQUESTS  the  Director-General  to undertake  a study  of the  most  feasible  means  of indicating  by a uniform  system  of marking  the  limits  of shelf  life  of pharmaceutical  products  under  the  conditions  of their 
storage,  as well  as the date  of manufacture  and  batch  number,  and  the maintenance  of records  which  facilitate 
tracing  of distribution,  and  to report  thereon  to a future  World  Health  Assembly. 
Handb.  Res.,  11th  ed.，1.9.1.1;  1.9.3  Fifteenth  plenary  meeting,  26  May  1972 
(Committee  A,  fifth  report) 
